Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

What does positron emission tomography offer oncology?

Anderson H, Price P.

Eur J Cancer. 2000 Oct;36(16):2028-35. Review.

PMID:
11044638
2.

Advances in FDG PET probes in surgical oncology.

Essner R, Daghighian F, Giuliano AE.

Cancer J. 2002 Mar-Apr;8(2):100-8. Review.

PMID:
11999944
3.

[Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].

Comans EF, Hoekstra OS, Hoekman K, van der Hoeven JJ, Golding RP, Teule GJ.

Ned Tijdschr Geneeskd. 2000 Aug 5;144(32):1520-8. Review. Dutch.

PMID:
10949634
4.

Clinical applications of FDG-PET in oncology.

Czernin J.

Acta Med Austriaca. 2002;29(5):162-70. Review.

PMID:
12506767
5.

[Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].

Soepenberg O.

Ned Tijdschr Geneeskd. 2000 Oct 7;144(41):1979-80. Dutch. No abstract available.

PMID:
11048563
6.

A brief history of positron emission tomography (PET).

Wagner HN Jr.

Semin Nucl Med. 1998 Jul;28(3):213-20.

PMID:
9704363
7.
8.

PET FDG studies in oncology.

Hawkins RA, Hoh CK.

Nucl Med Biol. 1994 Jul;21(5):739-47.

PMID:
9241650
9.

PET scan imaging in oncology.

Jerusalem G, Hustinx R, Beguin Y, Fillet G.

Eur J Cancer. 2003 Jul;39(11):1525-34. Review.

PMID:
12855258
10.

[18F FDG PET- applications in oncology].

Răileanu I, Rusu V, Stefănescu C, Cinotti L.

Rev Med Chir Soc Med Nat Iasi. 2001 Oct-Dec;105(4):638-45. Review. Romanian.

PMID:
12092212
12.

A shifting landscape: what will be next FDG in PET oncology?

Inoue T, Oriuchi N, Tomiyoshi K, Endo K.

Ann Nucl Med. 2002 Feb;16(1):1-9. Review.

PMID:
11922202
13.

[Present status of PET images: clinical FDG PET in oncology].

Inoue T.

Nihon Igaku Hoshasen Gakkai Zasshi. 1999 Nov;59(13):737-44. Review. Japanese.

PMID:
10614103
14.

[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].

Granov AM, Tiushin LA, Tlostanova MS, Kostenikov NA, Ryzhkova DV, Savello VE, Stanzhevskiĭ AA.

Vopr Onkol. 2003;49(5):563-73. Russian.

PMID:
14682126
15.

18-Fluorodeoxyglucose imaging in oncology.

Harolds JA.

J Okla State Med Assoc. 1999 Sep;92(9):457-61. Review.

PMID:
10504797
16.

PET scanning and measuring the impact of treatment.

Cohade C, Wahl RL.

Cancer J. 2002 Mar-Apr;8(2):119-34. Review.

PMID:
11999946
17.

Guest editorial: the conception of FDG-PET imaging.

Alavi A, Reivich M.

Semin Nucl Med. 2002 Jan;32(1):2-5. No abstract available.

PMID:
11839067
18.

PET scanning in malignancy: infant, adolescent or mature citizen?

Brennan MF.

Ann Surg. 2001 Mar;233(3):320-1. No abstract available.

19.

[Role of 18F-FDG positron emission tomography in surgical evaluation].

Franzius C, Sciuk J, Schober O.

Langenbecks Arch Chir Suppl Kongressbd. 1998;115:261-9. Review. German.

PMID:
9931622
20.

Positron emission tomography scanning: current and future applications.

Czernin J, Phelps ME.

Annu Rev Med. 2002;53:89-112. Review.

PMID:
11818465
Items per page

Supplemental Content

Support Center